New book by Larry Connors Click here Improve your trading - See how
Visit: http://www.stockguru.com to register for our daily Stocks to Watch and Trade Alerts.
China Natural Gas, Inc. (OTCBB: CHNG | Quote | Chart | News | PowerRating) Shares traded up 2.71% at $3.03
China Natural Gas, Inc., ("CHNG"), is the first China-based natural gas retailing company publicly traded in the U.S. It currently owns and operates a network of CNG retail filling stations as well as a 120 kilometer long compressed natural gas pipeline in Xi'an, China. Xi'an is a fast growing Chinese city supported by a population of approximately 8.5 million and is the "gateway" to the broad Western regions of China. CHNG currently retails natural gas at company-owned filling stations, delivers natural gas services to residential, commercial and industrial customers, and converts gasoline-fueled vehicles to hybrid (natural gas/gasoline) powered vehicles. Currently it is estimated that there are 5,000 buses and 20,000 taxis using CNG in Xi'an.
CHNG News Yesterday, China Natural Gas announced that it has completed the acquisition of Lingbao Yuxi Natural Gas Co. Ltd. ("Lingbao Yuxi"), including the land use right to 0.5 acres and all of its exclusive business operation rights in Lingbao City, in a cash transaction of RMB134 million. In conjunction with this acquisition, the Company has also secured abundant supply of natural gas to support its future expansion in the Henan province.
Genta Incorporated (OTCBB: GNTA | Quote | Chart | News | PowerRating) Shares traded up 102.70% at $0.0075
Genta Incorporated operates as a biopharmaceutical company with a diversified product portfolio that is focused on delivering products for the treatment of patients with cancer. Its research portfolio consists of two programs, DNA/RNA Medicines and Small Molecules. The company's lead compound from its DNA/RNA Medicines program is Genasense (oblimersen sodium) injection that is designed to block the production of a protein, known as Bcl-2, which is a fundamental cause of the inherent resistance of cancer cells to anticancer treatments, such as chemotherapy, radiation, and monoclonal antibodies. Genta Incorporated is recruiting patients to the AGENDA Trial, a global Phase III trial of Genasense in patients with advanced melanoma. Its lead drug in its Small Molecule program is Ganite (gallium nitrate injection), which is marketed in the United States for the treatment of symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. The company also develops G4544, an oral formulation of the active ingredient in Ganite, which entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. In addition, it is developing tesetaxel, an orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. The company was founded in 1988 and is based in Berkeley Heights, New Jersey.
GNTA News Yesterday, Genta announced that the Company has received notice from the U.S. Food and Drug Administration (FDA) that tesetaxel, the latest addition to Genta's oncology product portfolio, has been granted designation as an "Orphan Drug" for treatment of patients with advanced gastric cancer. Orphan drug status provides for a period of marketing exclusivity, certain tax benefits, and an exemption from certain fees upon submission of a New Drug Application. As a late Phase 2 agent, the Company believes tesetaxel is the leading oral taxane currently in clinical development.
China 3C Group (OTCBB: CHCG | Quote | Chart | News | PowerRating) Shares traded up 1.39% at $0.89
China 3C is a leading wholesale distributor and retailer of 3C merchandise: computers, communication products and consumer electronics. The company specializes in wholesale distribution and retail sales of 3C products in Eastern China, focusing on products that make life more comfortable, convenient and connected. The company's goal is to become the number one retailer of 3C products in China.
CHCG News Yesterday, China 3C Group announced that its CEO, Mr. Zhenggang Wang was named an "Outstanding Private Entrepreneur of China" at the Fifth Annual China Private Economy Summit. The award was in recognition of Mr. Wang's outstanding leadership as well as China 3C group's outstanding contributions to China's private economy. China 3C Group (OTC Bulletin Board: CHCG - News), a retailer and wholesale distributor of consumer and business products in China, today announced that its CEO, Mr. Zhenggang Wang was named an "Outstanding Private Entrepreneur of China" at the Fifth Annual China Private Economy Summit. The award was in recognition of Mr. Wang's outstanding leadership as well as China 3C group's outstanding contributions to China's private economy.
International Stem Cell Corporation (OTCBB: ISCO | Quote | Chart | News | PowerRating) Shares traded up 14.29% at $0.20
International Stem Cell Corporation is a California biotechnology company focused on developing therapeutic and research products. ISCO's technology, Parthenogenesis, results in the creation of pluripotent human stem cell lines from unfertilized human eggs. ISCO scientists have created the first Parthenogenetic homozygous stem cell line (phSC-Hhom-4) that can be a source of therapeutic cells that will minimize immune rejection after transplantation into hundreds of millions of individuals of differing sexes, ages and racial groups. These advancements offer the potential to create the first true "Stem Cell Bank" and address ethical issues by eliminating the need to use or destroy fertilized embryos. ISCO also produces and markets specialized cells and growth media worldwide for therapeutic research through its subsidiary Lifeline Cell Technology.
ISCO News Yesterday, International Stem Cell announced on December 30 that it had received the first $1 million tranche of an anticipated private equity financing of up to $5 million to be funded over the next several months. Officials of the Company commented today on the significance of that funding. "This is a first major step toward the Company's goal of becoming financially self-sufficient," said Kenneth Aldrich, CEO of the Company. Mr. Aldrich noted that the anticipated $5 million of funding is targeted toward three objectives: (1) eliminating $1 million of outstanding secured debt; (2) supporting critical first quarter pre-clinical trials that could be instrumental in enabling corporate joint venture financing; and (3) providing marketing and expansion capital designed to increase revenues from the Company's "Lifeline" subsidiary, which makes and sells specialty cells and growth media. "Although additional financing will be needed in 2009 to reach our goal, we believe our Lifeline subsidiary has the ability to bring the company to profitability within 2 years and support the clinical research of the company thereafter," said Jeffrey Janus, President and Chief Operating Officer of ISCO and CEO of its Lifeline subsidiary.
WorldWater & Solar Technologies Corp (OTCBB: WWAT | Quote | Chart | News | PowerRating) Shares traded down 12.47% at $0.2801
WorldWater & Solar Technologies Corp. is a full-service, solutions-driven solar electric engineering and design company offering unique, high-powered and patented solar technology. ENTECH, Inc., a subsidiary of WorldWater, is a high-technology solar energy company specializing in patented solar concentrating and CPVT (Concentrating Photovoltaic Thermal) systems. ENTECH's systems can produce electrical output, a combination of electricity and thermal energy or thermal energy alone. Commercial applications vary in size from one kilowatt remote power units to large, multi-megawatt utility power plants.
WWAT News Yesterday, WorldWater & Solar Technologies announced that it has completed installation of a 1.1 MW solar power system for the Valley Center Municipal Water District (VCMWD) of Valley Center, California. The system, which was financed and will be owned, operated, and maintained by Solar Power Partners, Inc. (SPP) of Mill Valley, California, will provide 2.1 million kWh per year of electricity for the district, offsetting up to 20% of the electricity required by their largest pumping station.
Studio One Media, Inc. (OTCBB: SOMD | Quote | Chart | News | PowerRating) Shares traded up 0.84% at $1.20
Studio One Media, Inc. engages in the development and manufacture of an interactive audio/video recording studio designed for installation in shopping malls and other pedestrian high traffic public areas in the United States. The company primarily offers MyStudio video recording studio, which enables the public, for a fee, to step into a sound proof recording studio and record a three minute video in a private, and enter their performances in music, modeling, and other talent related contests. Its MyStudio is also used to record video resumes, dating profiles, and personal messages. In addition the company is developing a Web site that incorporates various features, such as networking functionality, daily video postings, monthly contests, and member profile pages. Studio One Media is based in Scottsdale, Arizona.
SOMD News Yesterday, Studio One Media announced that it has partnered with New York's famed Gotham Comedy Club for MyStudio's first comedy contest, "The MyStudio Gotham Comedy Challenge." The contest gives MyStudio users the opportunity to participate in a nationwide comedy talent search that could launch a career in comedy. The winner will receive an all expenses paid trip to New York for a paid booking at the Gotham Comedy Club and an audition for the upcoming television program "Live At Gotham," on Comedy Central. The contest runs from January 1 through January 31, 2009.
About StockGuru.com:
StockGuru.com is an investment information web site for smallcap and over-the-counter bulletin board stocks. StockGuru features daily email alerts to members, company profiles, audio interviews of CEO's or other key executives, and company news. Company and financial reports are authored by business analysts. To join our email alert list, please visit: http://www.stockguru.com/index.php?option=com_content&view=article&id=31&Itemid=5
About ShareholderVision.com:
Occasionally companies mentioned are also featured at ShareholderVision.com. This innovative web site featuring company videos of corporate executives and key personnel. All videos are shot in high-definition format and are edited for content purposes.
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031, or you email us at email: john@stockguru.com and we will gladly send you more information on featuring your company with StockGuru.com
Stockguru.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.
CONTACT: John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com WWW: http://www.stockguru.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
